🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Immediate Release (IR) Formulation

Found 0 matching trials

Converting From Ropinirole Immediate Release (IR) To Ropinirole Controlled-Release for RLS (Restless Legs Syndrome)

PHASE3

This is a multi-center, Phase III study to evaluate the safety and tolerabi...

Status

Completed

Location

GSK Investigational Site

Start Date

2005-11-14

Trial ID

NCT00256854

Treatments Being Tested

Ropinirole IR 1 mg Ropinirole IR 2 mg Ropinirole IR 1 mg Placebo Ropinirole IR 2 mg Placebo Ropinirole CR 2 mg Ropinirole CR 3 mg Ropinirole CR 2 mg Placebo Ropinirole CR 3 mg Placebo

Study Evaluating the Bioavailability of Miricorilant With Optional Food Effect Assessment in Healthy Adult Subjects

PHASE1

This single-center, randomized, open-label study will assess the relative b...

Status

Completed

Location

Site 01

Start Date

2025-09-11

Trial ID

NCT07240116

Treatments Being Tested

Miricorilant Treatment A Miricorilant Treatment B Miricorilant Treatment C Miricorilant Treatment D

Ropinirole Tablets In Young Patients With Restless Legs Syndrome

PHASE1

This is a two-period dose rising study of Ropinirole Immediate Release in a...

Status

Completed

Location

GSK Investigational Site

Start Date

2005-06-10

Trial ID

NCT00140712

Treatments Being Tested

Ropinirole Immediate Release

A Study to Assess the Bioavailability and Effect of Food of BMS-986419 Immediate-release Tablet Formulation in Healthy Adult Participants

PHASE1

The purpose of this study is to assess the impact of the BMS-986419 new imm...

Status

Completed

Location

Anaheim Clinical Trials

Start Date

2023-08-08

Trial ID

NCT05963932

Treatments Being Tested

BMS-986419 DR Capsule BMS-986419 IR Tablet

A 5-Period, Single Dose, Phase 1 Study in Healthy Elderly Subjects to Assess Relative Bioavailability and Food Effect of Two Oral Formulations of GSK1325756 (Free Base vs HBr Salt) and Food Effect on the HBr Formulation When Given With Omeprazole

PHASE1

The current study will help to increase our understanding of the pharmacoki...

Status

Completed

Location

GSK Investigational Site

Start Date

2015-05-18

Trial ID

NCT02453022

Treatments Being Tested

Danirixin HBr 50 mg IR Tablet Danirixin FB 50 mg IR Tablet Prilosec (omeprazole) 40mg Delayed-Release capsule

An Investigation Of The Absorption And Pharmacokinetics Of A Single Dose Of A Controlled Release (CR) Pregabalin Tablet Following A Low, Medium, And High-Fat Evening Meal As Compared To A Single Dose Of The Immediate Release (IR) Pregabalin Capsule In Healthy Volunteers

PHASE1

The purpose of this study is to 1) evaluate the extent of absorption of a s...

Status

Completed

Location

Pfizer Investigational Site

Start Date

2011-03

Trial ID

NCT01257529

Treatments Being Tested

Pregabalin controlled release, 330 mg, low-fat Pregabalin controlled release, 330 mg, medium-fat Pregabalin controlled release, 330 mg, high-fat Pregabalin immediate release, 300 mg

A Phase 1 Study to Evaluate Safety, Tolerability, and Pharmacokinetics of TBI-223 in Healthy Adults

PHASE1

Partially-Blinded, Placebo-Controlled, Randomized, Single Ascending Dose (S...

Status

Completed

Location

Worldwide Clinical Trials (WCT)

Start Date

2019-01-16

Trial ID

NCT03758612

Treatments Being Tested

TBI-223 oral suspension TBI-223 enteric capsule TBI-223 SR Tablet Prototype 1 TBI-223 SR Tablet Prototype 2 TBI-223 SR Tablet Prototype 3 TBI-223 IR Tablet Placebo suspension

A Randomized, Double-blind, Flexible Dose, Multicenter Study to Evaluate the Effectiveness and Safety of Galantamine IR in Mild to Moderate Alzheimer's Disease

PHASE3

The purpose of this randomized, double-blind, active-controlled, flexible d...

Status

Completed

Location

Multiple Locations

Start Date

2004-03

Trial ID

NCT00645190

Treatments Being Tested

Galantamine HBr

A Study Versus E2020 10mg Followed by an Open-label Extension Phase to Explore the Safety of E2020 SR 23 mg in Japanese Subjects With Severe Alzheimer's Type Dementia

PHASE2

The purpose of this study is to compare 23 mg donepezil sustained release (...

Status

Completed

Location

Multiple Locations

Start Date

2011-01

Trial ID

NCT01276353

Treatments Being Tested

E2020 E2020

Bioavailability and Food Effect Study of Gelatin Formulation and Immediate Release Tablet Formulation of Afuresertib

PHASE1

This study is being conducted to measure the relative bioavailability of th...

Status

Completed

Location

GSK Investigational Site

Start Date

2014-02-05

Trial ID

NCT02040480

Treatments Being Tested

GSK2110183 Gelatin Capsule GSK2110183 IR Tablet

Previous Next